Please select the option that best describes you:

How would you treat a newly diagnosed hormone sensitive high risk prostate cancer with one small lung metastasis and no other evidence of metastatic disease per PSMA PET?   

Per the NCCN guidelines and clinical trials, the patient does not fit the criteria for low metastatic burden, and therefore the benefit of radiation to the prostate is questionable. (Per NCCN: "Conventional imaging defined number of bony metastases without visceral involvement may be preferred to define candidacy for treatment of the primary tumor".) Would you treat the prostate? Would you treat the lung met? Systemic therapy alone?



Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at MultiCare Deaconess Hospital
Dr. @Patel, I very much appreciate your answer! It...
Radiation Oncologist at Quillen VA Medical Center
I knew NCCN would be useless for your unique case,...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more